HCC	hepatocellular carcinoma
NASH	non-alcoholic steatohepatitis
SIRT-3	sirtuin-3
T2DM	type 2 diabetes mellitus
mTOR	mammalian target of rapamycin
AMPK	AMP-activated protein kinase
HIF-1α	hypoxia-induced factor-1α
AASLD	American Association for the Study of Liver Diseases
IQR	interquartile range
DFS	disease-free survival
PFS	progression-free survival
OS	overall survival
FBS	fetal bovine serum
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
DMSO	dimethyl sulfoxide
IR	insulin resistance